Compounds > pyridostigmine bromide
Page last updated: 2024-08-18

pyridostigmine bromide and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

pyridostigmine bromide has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jandial, A; Kopp, CR; Malhotra, P; Mishra, K; Sandal, R1

Other Studies

1 other study(ies) available for pyridostigmine bromide and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

ArticleYear
Myasthenia gravis unmasked by imatinib.
    British journal of haematology, 2019, Volume: 184, Issue:3

    Topics: Adult; Blepharoptosis; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Myasthenia Gravis; Neostigmine; Prednisolone; Pyridostigmine Bromide

2019